UK markets closed
  • NIKKEI 225

    28,820.09
    -278.15 (-0.96%)
     
  • HANG SENG

    25,555.73
    -73.01 (-0.28%)
     
  • CRUDE OIL

    83.06
    +0.40 (+0.48%)
     
  • GOLD FUTURES

    1,800.60
    +1.80 (+0.10%)
     
  • DOW

    35,730.48
    +239.79 (+0.68%)
     
  • BTC-GBP

    43,982.16
    +1,107.39 (+2.58%)
     
  • CMC Crypto 200

    1,491.73
    +72.36 (+5.10%)
     
  • ^IXIC

    15,448.12
    +212.28 (+1.39%)
     
  • ^FTAS

    4,137.54
    -1.14 (-0.03%)
     

Global Molecular Quality Controls Market to Reach $280.1 Million by 2027

·25-min read

Abstract: - Global Molecular Quality Controls Market to Reach $280. 1 Million by 2027. - Amid the COVID-19 crisis, the global market for Molecular Quality Controls estimated at US$155.

New York, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Molecular Quality Controls Industry" - https://www.reportlinker.com/p06032265/?utm_source=GNW
5 Million in the year 2020, is projected to reach a revised size of US$280.1 Million by 2027, growing at aCAGR of 8.8% over the period 2020-2027. Independent Controls, one of the segments analyzed in the report, is projected to record 8.1% CAGR and reach US$170.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instrument-Specific Controls segment is readjusted to a revised 9.9% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $46 Million, While China is Forecast to Grow at 8.2% CAGR
- The Molecular Quality Controls market in the U.S. is estimated at US$46 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$48.8 Million by the year 2027 trailing a CAGR of 8.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.1% and 7.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.

- Select Competitors (Total 33 Featured) -

  • Abbott Laboratories

  • Bio-Rad Laboratories, Inc.

  • Danaher

  • F. Hoffmann-La Roche Ltd

  • Helena Biosciences Europe

  • Maine Molecular Quality Controls, Inc.

  • Microbiologics, Inc.

  • Qnostics

  • Quidel Corporation

  • Randox Laboratories Ltd.

  • SeraCare Life Sciences, Inc.

  • SERO AS

  • Technopath Clinical Diagnostics

  • Thermo Fisher Scientific Inc.

  • ZeptoMetrix Corporation




Read the full report: https://www.reportlinker.com/p06032265/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Molecular Quality
Controls by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR

Table 2: World Historic Review for Molecular Quality Controls
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Molecular Quality
Controls by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Independent
Controls by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR

Table 5: World Historic Review for Independent Controls by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Independent Controls by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for
Instrument-Specific Controls by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Instrument-Specific Controls
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Instrument-Specific
Controls by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Single-Analyte
Controls by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR

Table 11: World Historic Review for Single-Analyte Controls by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Single-Analyte Controls
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Multi-Analyte
Controls by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR

Table 14: World Historic Review for Multi-Analyte Controls by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Multi-Analyte Controls
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Oncology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Oncology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Oncology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 19: World Current & Future Analysis for Genetic Testing
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Genetic Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Genetic Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Infectious
Diseases by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR

Table 23: World Historic Review for Infectious Diseases by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Infectious Diseases by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR

Table 26: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 28: USA Current & Future Analysis for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 29: USA Historic Review for Molecular Quality Controls by
Product - Independent Controls and Instrument-Specific Controls
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 30: USA 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027

Table 31: USA Current & Future Analysis for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Molecular Quality Controls by
Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027

Table 34: USA Current & Future Analysis for Molecular Quality
Controls by Application - Oncology, Genetic Testing, Infectious
Diseases and Other Applications - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 35: USA Historic Review for Molecular Quality Controls by
Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 36: USA 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027

CANADA
Table 37: Canada Current & Future Analysis for Molecular
Quality Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 38: Canada Historic Review for Molecular Quality Controls
by Product - Independent Controls and Instrument-Specific
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 39: Canada 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027

Table 40: Canada Current & Future Analysis for Molecular
Quality Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 41: Canada Historic Review for Molecular Quality Controls
by Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 42: Canada 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027

Table 43: Canada Current & Future Analysis for Molecular
Quality Controls by Application - Oncology, Genetic Testing,
Infectious Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 44: Canada Historic Review for Molecular Quality Controls
by Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 45: Canada 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027

JAPAN
Table 46: Japan Current & Future Analysis for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 47: Japan Historic Review for Molecular Quality Controls
by Product - Independent Controls and Instrument-Specific
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 48: Japan 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027

Table 49: Japan Current & Future Analysis for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 50: Japan Historic Review for Molecular Quality Controls
by Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 51: Japan 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027

Table 52: Japan Current & Future Analysis for Molecular Quality
Controls by Application - Oncology, Genetic Testing, Infectious
Diseases and Other Applications - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 53: Japan Historic Review for Molecular Quality Controls
by Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 54: Japan 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027

CHINA
Table 55: China Current & Future Analysis for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 56: China Historic Review for Molecular Quality Controls
by Product - Independent Controls and Instrument-Specific
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 57: China 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027

Table 58: China Current & Future Analysis for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 59: China Historic Review for Molecular Quality Controls
by Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 60: China 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027

Table 61: China Current & Future Analysis for Molecular Quality
Controls by Application - Oncology, Genetic Testing, Infectious
Diseases and Other Applications - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 62: China Historic Review for Molecular Quality Controls
by Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 63: China 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027

EUROPE
Table 64: Europe Current & Future Analysis for Molecular
Quality Controls by Geographic Region - France, Germany, Italy,
UK and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ for Years 2020 through 2027 and % CAGR

Table 65: Europe Historic Review for Molecular Quality Controls
by Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 66: Europe 15-Year Perspective for Molecular Quality
Controls by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2012, 2020 & 2027

Table 67: Europe Current & Future Analysis for Molecular
Quality Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 68: Europe Historic Review for Molecular Quality Controls
by Product - Independent Controls and Instrument-Specific
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 69: Europe 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027

Table 70: Europe Current & Future Analysis for Molecular
Quality Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 71: Europe Historic Review for Molecular Quality Controls
by Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027

Table 73: Europe Current & Future Analysis for Molecular
Quality Controls by Application - Oncology, Genetic Testing,
Infectious Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 74: Europe Historic Review for Molecular Quality Controls
by Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 75: Europe 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027

FRANCE
Table 76: France Current & Future Analysis for Molecular
Quality Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 77: France Historic Review for Molecular Quality Controls
by Product - Independent Controls and Instrument-Specific
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 78: France 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027

Table 79: France Current & Future Analysis for Molecular
Quality Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 80: France Historic Review for Molecular Quality Controls
by Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 81: France 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027

Table 82: France Current & Future Analysis for Molecular
Quality Controls by Application - Oncology, Genetic Testing,
Infectious Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 83: France Historic Review for Molecular Quality Controls
by Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 84: France 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027

GERMANY
Table 85: Germany Current & Future Analysis for Molecular
Quality Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 86: Germany Historic Review for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 87: Germany 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027

Table 88: Germany Current & Future Analysis for Molecular
Quality Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 89: Germany Historic Review for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 90: Germany 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027

Table 91: Germany Current & Future Analysis for Molecular
Quality Controls by Application - Oncology, Genetic Testing,
Infectious Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 92: Germany Historic Review for Molecular Quality
Controls by Application - Oncology, Genetic Testing, Infectious
Diseases and Other Applications Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 93: Germany 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027

ITALY
Table 94: Italy Current & Future Analysis for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 95: Italy Historic Review for Molecular Quality Controls
by Product - Independent Controls and Instrument-Specific
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 96: Italy 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027

Table 97: Italy Current & Future Analysis for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 98: Italy Historic Review for Molecular Quality Controls
by Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 99: Italy 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027

Table 100: Italy Current & Future Analysis for Molecular
Quality Controls by Application - Oncology, Genetic Testing,
Infectious Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 101: Italy Historic Review for Molecular Quality Controls
by Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 102: Italy 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 103: UK Current & Future Analysis for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 104: UK Historic Review for Molecular Quality Controls by
Product - Independent Controls and Instrument-Specific Controls
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR

Table 105: UK 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027

Table 106: UK Current & Future Analysis for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 107: UK Historic Review for Molecular Quality Controls by
Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 108: UK 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027

Table 109: UK Current & Future Analysis for Molecular Quality
Controls by Application - Oncology, Genetic Testing, Infectious
Diseases and Other Applications - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 110: UK Historic Review for Molecular Quality Controls by
Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 111: UK 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 112: Rest of Europe Current & Future Analysis for
Molecular Quality Controls by Product - Independent Controls
and Instrument-Specific Controls - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 113: Rest of Europe Historic Review for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 114: Rest of Europe 15-Year Perspective for Molecular
Quality Controls by Product - Percentage Breakdown of Value
Sales for Independent Controls and Instrument-Specific Controls
for the Years 2012, 2020 & 2027

Table 115: Rest of Europe Current & Future Analysis for
Molecular Quality Controls by Analyte Type - Single-Analyte
Controls and Multi-Analyte Controls - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 116: Rest of Europe Historic Review for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 117: Rest of Europe 15-Year Perspective for Molecular
Quality Controls by Analyte Type - Percentage Breakdown of
Value Sales for Single-Analyte Controls and Multi-Analyte
Controls for the Years 2012, 2020 & 2027

Table 118: Rest of Europe Current & Future Analysis for
Molecular Quality Controls by Application - Oncology, Genetic
Testing, Infectious Diseases and Other Applications -
Independent Analysis of Annual Sales in US$ for the Years 2020
through 2027 and % CAGR

Table 119: Rest of Europe Historic Review for Molecular Quality
Controls by Application - Oncology, Genetic Testing, Infectious
Diseases and Other Applications Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 120: Rest of Europe 15-Year Perspective for Molecular
Quality Controls by Application - Percentage Breakdown of Value
Sales for Oncology, Genetic Testing, Infectious Diseases and
Other Applications for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 121: Asia-Pacific Current & Future Analysis for Molecular
Quality Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 122: Asia-Pacific Historic Review for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 123: Asia-Pacific 15-Year Perspective for Molecular
Quality Controls by Product - Percentage Breakdown of Value
Sales for Independent Controls and Instrument-Specific Controls
for the Years 2012, 2020 & 2027

Table 124: Asia-Pacific Current & Future Analysis for Molecular
Quality Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 125: Asia-Pacific Historic Review for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 126: Asia-Pacific 15-Year Perspective for Molecular
Quality Controls by Analyte Type - Percentage Breakdown of
Value Sales for Single-Analyte Controls and Multi-Analyte
Controls for the Years 2012, 2020 & 2027

Table 127: Asia-Pacific Current & Future Analysis for Molecular
Quality Controls by Application - Oncology, Genetic Testing,
Infectious Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 128: Asia-Pacific Historic Review for Molecular Quality
Controls by Application - Oncology, Genetic Testing, Infectious
Diseases and Other Applications Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 129: Asia-Pacific 15-Year Perspective for Molecular
Quality Controls by Application - Percentage Breakdown of Value
Sales for Oncology, Genetic Testing, Infectious Diseases and
Other Applications for the Years 2012, 2020 & 2027

REST OF WORLD
Table 130: Rest of World Current & Future Analysis for
Molecular Quality Controls by Product - Independent Controls
and Instrument-Specific Controls - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 131: Rest of World Historic Review for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 132: Rest of World 15-Year Perspective for Molecular
Quality Controls by Product - Percentage Breakdown of Value
Sales for Independent Controls and Instrument-Specific Controls
for the Years 2012, 2020 & 2027

Table 133: Rest of World Current & Future Analysis for
Molecular Quality Controls by Analyte Type - Single-Analyte
Controls and Multi-Analyte Controls - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 134: Rest of World Historic Review for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 135: Rest of World 15-Year Perspective for Molecular
Quality Controls by Analyte Type - Percentage Breakdown of
Value Sales for Single-Analyte Controls and Multi-Analyte
Controls for the Years 2012, 2020 & 2027

Table 136: Rest of World Current & Future Analysis for

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032265/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting